CX3CR1 and infection: In further receptor independent infection experiments using 10 and 100 μM of antagonist for CX3CR1, human microglial cells at 2dcc displayed reduced cell death levels in presence of antagonist in a dose dependent fashion (Supplementary Figure 2d).